Connect
← Return to Stage 4 prostate Cancer: Firmagon + Abiraterone?
Discussion
Stage 4 prostate Cancer: Firmagon + Abiraterone?
Prostate Cancer | Last Active: Oct 3, 2022 | Replies (19)Comment receiving replies
Good add, @msciulli.
Here's more info about darolutamide (Nubeqa) and it's recent (Aug 2022) approval:
- FDA approves darolutamide tablets for metastatic hormone-sensitive prostate cancer https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-darolutamide-tablets-metastatic-hormone-sensitive-prostate-cancer
Has darolutamide been recommended for you Msciulli?
Replies to "Good add, @msciulli. Here's more info about darolutamide (Nubeqa) and it's recent (Aug 2022) approval: -..."
It has been prescribed but waiting to see if insurance will approve. Pre-PSMA scan, would have been considered metastatic, but post-PSMA are now not metastatic, but high probability of micro-metastatic and extracapsular extension, so don't know if it will fit within the tight constraints of FDA approval. Also using Orgovyx - daily pill, fewer cardiac complications and avoids the firmagon shot.
Connect
March of 2022 I had a psa of 80 w Pelvic lymph node (2) involvement, Gleason 7 ++,
Treated w 39 IMRT sessions (May-June) and 6 mos LUPRON (Local provider).
PSA (Aug 2022)=1.2
Stared ABIRATERONE (Zytiga) Sept 1 2022.
PSA on (Sept 19, 2022)=0.4
Refresh of LUPRON on Sept 22, 2022
This is a brag for Mayo (Phoenix).
This would not be possible without Mayo's willingness to work with the VA. Thanks to the VA for working w Mayo.
Despite the rosy numbers I still have a long and difficult journey.
The treatment is not without SIDE EFFECTS.
I am happy to am happy to answer any questions.